Moody's Rates Royalty Pharma Pharmaceutical Royalty Securitization Aaa

Approximately $225 Million of Asset-Backed Securities Rated Aaa.
New York – July 30, 2003 – Moody’s Investors Service has assigned a rating of Aaa to the $225,000,000 asset-backed note issued by Royalty Pharma Finance Trust (RPFT). The notes are backed initially by a pool of royalty interests and contingent pay rights in thirteen biopharmaceutical products. This is the first time Moody’s has assigned a term rating to a transaction backed by biopharmaceutical royalty interests.

Source: Original Article